Despite advances in the treatment of many pediatric solid tumors, children with aggressive and high-risk disease continue to have a dismal prognosis. For those presenting with metastatic or recurrent disease, multiple rounds of intensified chemotherapy and radiation are the typical course of action, but more often than not, this fails to control the progression of the disease. Thus, new therapeutics are desperately needed to improve the outcomes for these children. Recent advances in our understanding of both the immune system's biology and its interaction with tumors have led to the development of novel immunotherapeutics as alternative treatment options for these aggressive malignancies. Immunotherapeutic approaches have shown promising results for pediatric solid tumors in early clinical trials, but challenges remain concerning safety and anti-tumor efficacy. In this review, we aim to discuss and summarize the main classes of immunotherapeutics used to treat pediatric solid tumors.
Keywords: cancer vaccines; chimeric antigen receptors; immune checkpoint inhibitors; immunomodulation; immunotherapy; oncolytic viral therapy; pediatric solid tumors.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Cellular immunotherapy for pediatric solid tumors.Cytotherapy. 2015 Jan;17(1):3-17. doi: 10.1016/j.jcyt.2014.05.019. Epub 2014 Jul 28. Cytotherapy. 2015. PMID: 25082406 Free PMC article. Review.
New developments in immunotherapy for pediatric solid tumors.Curr Opin Pediatr. 2018 Feb;30(1):30-39. doi: 10.1097/MOP.0000000000000564. Curr Opin Pediatr. 2018. PMID: 29189429 Review.
Perspectives on immunotherapy via oncolytic viruses.Infect Agent Cancer. 2019 Feb 11;14:5. doi: 10.1186/s13027-018-0218-1. eCollection 2019. Infect Agent Cancer. 2019. PMID: 30792754 Free PMC article. Review.
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.Front Immunol. 2018 May 22;9:1104. doi: 10.3389/fimmu.2018.01104. eCollection 2018. Front Immunol. 2018. PMID: 29872437 Free PMC article. Review.
Immunotherapy for Pediatric Brain Tumors.Brain Sci. 2017 Oct 21;7(10):137. doi: 10.3390/brainsci7100137. Brain Sci. 2017. PMID: 29065490 Free PMC article. Review.